The National Library of Medicine is the world's largest medical library. The NLM is a component of the National Institutes of Health (NIH) which is a large, federal biomedical research organization dedicated to the mission of uncovering new knowledge that will lead to better health for everyone. The Library's primary mission, as mandated by Congress, is to provide biomedical and health care literature and information to health professionals. To support this mission, the Library collects publications in all areas of biomedicine from every country in the world, and in every language according to the guidelines described in the current education of the Collection Development Manual of the National Library of Medicine https://www.nlm.nih.gov/tsd/acquisitions/cdm/. The focus of the collection is upon original research and works of international interest aimed at health professionals, scholars, and scientist. The Library's objective is to support biomedical life sciences research, professional education, health policy development and health care delivery through the dissemination and exchange of information by health professionals.
This is not a solicitation for competitive quotations, nor is a RFQ available. However, if any other interested party believes that it can meet the requirement it may submit a statement of capabilities.
The capability statement and any other information furnished must be in writing, and must contain material in sufficient detail to all NLM to determine if the party can meet all of the foregoing requirements.
Capability statements and related materials must be received in this office by 1:00 p.m. Eastern Standard Time (EST) on December 23, 2016 via e-mail to [email protected].
NLM Synopsis Number NIHLM2017918 shall be noted on all correspondence relating to this announcement. Inquiries regarding this procurement may be made to Elena Leon, Contracting Officer, NLM, via e-mail at [email protected] .
This solicitation incorporates provision and clauses in effect in the FAC 2005-92 FAR Revision effective November 18, 2016, including all FAR Circulars issued as of the date of this synopsis. NLM anticipates that an award will be made on or about January 10, 2017.
Vendors shall comply with all applicable Federal, State and Local laws, executive orders, rules and regulations applicable to its performance under this order. The following clauses and provisions cited herein are incorporated by reference into this announcement:
The following clauses and provisions cited herein are incorporated by reference into this announcement: FAR 52.212-1, Instructions to Offerors-Commercial Items (OCT 2016)
FAR 52.212-2, Evaluation-Commercial Items (OCT 2014). Offerors are advised to provide with their offer a completed copy of the following provisions:
FAR 52.212-3, Offeror Representations and Certifications- Commercial Items (Oct 2016)-With DUNS Number Addendum [52.204-6 (JUL 2013)].
The following FAR clauses apply to this acquisition: FAR 52.212-4, Contract Terms and Conditions-Commercial Items (MAY 2015)-With Addenda [Stop Work Order.
FAR 52.242-15 (AUG 1989) and Year 2000 Compliance (July 1997)]
FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (NOV 2016), as well as the following clauses cited therein
FAR 52.232-18, Availability of Funds (APR 1984)
FAR 52.242-15, Stop Work Order (AUG 1989) with Alternate I (Apr 1984); FAR 52.242-17, Government Delay of Work (APR 1984); and FAR 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (JUL 2013).
A determination by the government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
This notice does not commit the Government to award a contract. NO collect calls will be accepted. NO facsimile transmissions will be accepted.
ALL RESPONSIBLE SOURCES MAY SUBMIT A CAPABILITY STATEMENT, PROPOSAL, OR QUOTATION, WHICH IF TIMELY RECEIVED, SHALL BE CONSIDERED BY THE AGENCY.